# Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea

> **NCT01018160** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 1197 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Rabeprazole Sodium

## Key facts

- **NCT ID:** NCT01018160
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 1197 (ACTUAL)
- **Last updated:** 2014-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018160, "Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01018160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*